CastAR
CastAR was a technology company focused on the development of augmented reality (AR) glasses. The company's approach to AR involved projecting images onto a reflective surface, which then bounced back to the user's eyes, creating a holographic-like image that appeared to be in the real world. This method distinguished CastAR from other AR technologies that overlay digital content directly onto the real world through transparent lenses.
History
CastAR was founded by Jerri Ellsworth and Rick Johnson, two former Valve employees, who started the project in their garage. The company was initially part of Valve's hardware division but was spun off as an independent entity in 2013 when Valve decided to focus on virtual reality (VR) instead of AR. Following the spin-off, CastAR conducted a successful Kickstarter campaign to fund the development of their AR glasses.
Despite the initial excitement and potential, CastAR faced significant challenges. In 2017, the company abruptly shut down and laid off most of its staff due to financial difficulties. This closure marked the end of CastAR's efforts to bring their version of augmented reality to the consumer market.
Technology
CastAR's technology was based on a unique approach to augmented reality. Unlike traditional AR glasses, which use transparent displays to overlay digital images onto the real world, CastAR glasses projected images onto a specialized reflective surface. This surface was designed to reflect the light back to the glasses, which were equipped with tiny projectors and tracking sensors. The result was a 3D holographic display that users could interact with, making it suitable for a variety of applications, including gaming, education, and professional design.
The system also included a tracking system that monitored the user's head movements, allowing the projected images to adjust in real-time, providing a seamless and immersive experience.
Impact and Legacy
Although CastAR did not achieve commercial success, its innovative approach to augmented reality contributed to the broader development of AR technologies. The company's vision of creating a more interactive and immersive AR experience inspired other companies and developers to explore alternative methods of integrating digital content with the physical world.
Following the shutdown of CastAR, other companies have continued to advance AR technology, focusing on both projection-based systems and direct overlay methods. The work of CastAR remains a significant part of the history of augmented reality, demonstrating the potential and challenges of bringing AR to the consumer market.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD